On the other hand, nanoparticles decorated with specific monoclonal antibodies or ligands have been used as carriers allowing tumor-targeting drugs to access and detect tumor cells that express specific antigens or cell surface receptors [10]. The gene discussed is CD177; the disease is neoplasm.